MBD5
protein-codingmethyl-CpG binding domain protein 5, the group of Methyl-CpG binding domain containing|PWWP domain containing
Gene summary
This gene encodes a member of the methyl-CpG-binding domain (MBD) family. The MBD consists of about 70 residues and is the minimal region required for a methyl-CpG-binding protein binding specifically to methylated DNA. In addition to the MBD domain, this protein contains a PWWP domain (Pro-Trp-Trp-Pro motif), which consists of 100-150 amino acids and is found in numerous proteins that are involved in cell division, growth and differentiation. Mutations in this gene cause an autosomal dominant type of cognitive disability. The encoded protein interacts with the polycomb repressive complex PR-DUB which catalyzes the deubiquitination of a lysine residue of histone 2A. Haploinsufficiency of this gene is associated with a syndrome involving microcephaly, intellectual disabilities, severe speech impairment, and seizures. Alternatively spliced transcript variants have been found, but their full-length nature is not determined. [provided by RefSeq, Jul 2017]
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~496.0 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
Inheritance Pattern: AD
Disease ID:MONDO:0100038
Submitter: ClinGen
*MBD5* haploinsufficiency due to an intragenic deletion was first reported in relation to autosomal dominant complex neurodevelopmental disorder in 2007 (PMID: 17847001). This curation includes heterozygous deletions encompassing all or part of *MBD5* and *MBD5* truncating variants (PMID: 27786435). Duplications encompassing the entire *MBD5* have also been reported in individuals with neurodevelopmental disorders; as these typically also involve other genes and are likely acting via a different molecular mechanism, they are not included in this curation. Individuals with *MBD5* pathogenic variants present with developmental delay, intellectual disability, epilepsy, autism spectrum disorder, severe speech impairment, and behavioral problems (PMIDs: 23422940, 27786435, 33912662). Over 100 individuals with neurodevelopmental disorders and *MBD5* LoF variants have been reported in the literature (PMIDs: 17847001, 22495309, 22726846, 23422940, 23708187, 25356899, 27848944, 28807762, 29778030, 30763456, 32193494, 32238909, 33912662), but only 11 probands are included in this curation because the maximum score for genetic evidence has been reached. Most variants are *de novo*, although inheritance from parents with low level mosaicism has been reported in multiple affected individuals with *MBD5* LoF variants (PMIDs: 32238909, 33912662, 36396431). There have also been reports of probands with intragenic *MBD5* duplications (PMIDs: 23422940, 33912662), and expression analysis in one patient showed that the encoded aberrant transcripts resulted in premature termination (PMID: 23422940). The mechanism for disease is predicted to be haploinsufficiency (PMID: 23422940). The gene-disease relationship is also supported by experimental evidence, including a mouse model and a cell culture model (PMID: 25001218). In summary, there is definitive evidence to support the relationship between *MBD5* and autosomal dominant complex neurodevelopmental disorder. This classification was approved by the ClinGen Intellectual Disability and Autism Gene Curation Expert Panel on February 15, 2023 (SOP Version 9). This gene-disease pair was originally evaluated on November 21, 2018 and classified as moderate. Curation of additional genetic evidence resulted in the classification being updated
Inheritance Pattern: AD
Disease ID:MONDO:0015802
Submitter: Orphanet
Inheritance Pattern: AD
Disease ID:MONDO:0100038
Submitter: PanelApp Australia
Inheritance Pattern: AD
Disease ID:MONDO:0007974
Submitter: G2P
Inheritance Pattern: AD
Disease ID:MONDO:0007974
Submitter: Labcorp Genetics (formerly Invitae)
Clinical Genomic Database (CGD)
Manifestation: Craniofacial; Neurologic; Ophthalmologic
Intervention: General
Rationale: Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to MBD5 variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_001378120.1. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 10 | 381 | 3 | 394 | ||
| missense | 1 | 6 | 907 | 261 | 11 | 1186 |
| nonsense | 27 | 14 | 3 | 44 | ||
| start loss | 1 | 1 | ||||
| frameshift | 53 | 25 | 4 | 82 | ||
| splice donor/acceptor (+/-2bp) | 4 | 5 | 5 | 14 | ||
| Total | 85 | 51 | 929 | 642 | 14 | 1721 |
Highest pathogenic variant AF is 0.000010261266
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_001365049.1 | 10 | MANE Select | |
| Ensembl | ENSP00000493871.2 | 10 | MANE Select | |
| RefSeq | NP_001425783.1 | 10 | Standard | |
| RefSeq | NP_001425784.1 | 10 | Standard |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Pathways ConsensusPathDB
- Post-translational protein modification
- Metabolism of proteins
- UCH proteinases
- Deubiquitination
Biological Process
- nervous system development
- protein deubiquitination
- regulation of multicellular organism growth
- glucose homeostasis
- regulation of behavior
Molecular Function
- DNA binding
- chromatin binding
Cellular Component
- nucleus
- nucleoplasm
- chromocenter
- midbody
- extracellular exosome
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000407073
- Coding exons
- 10
- Length
- 497226
- Individuals with no LoFs
- 125742
- Homozygous LoFs
- 0
- Heterozygous LoFs
- 4
- Defined
- 125746
- p
- 0.0000159
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | 0.856 | 710 | 777 | 0.914 | 0.0000403 | 9822 |
| Missense (PolyPhen) | 35 | 42.073 | 0.83188 | 419 | ||
| Synonymous | -0.611 | 301 | 288 | 1.05 | 0.0000161 | 3033 |
| Loss of Function | 6.04 | 2 | 46.4 | 0.0431 | 0.00000244 | 595 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0 | 0.0 | absent |
| Latino/Admixed American | 0 | 0.0 | absent |
| Ashkenazi Jewish | 0 | 0.0 | absent |
| East Asian | 0 | 0.0 | absent |
| Finnish | 0 | 0.0 | absent |
| European (Non-Finnish) | 0.000026 | 0.000026 | rare |
| South Asian | 0 | 0.0 | absent |
| Other | 0.00016 | 0.00016 | rare |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: Binds to heterochromatin. Does not interact with either methylated or unmethylated DNA (in vitro).;
- Disease
- DISEASE: Mental retardation, autosomal dominant 1 (MRD1) [MIM:156200]: A disorder characterized by significantly below average general intellectual functioning associated with impairments in adaptive behavior and manifested during the developmental period. {ECO:0000269|PubMed:17847001, ECO:0000269|PubMed:22726846}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
Recessive Scores
- pRec
- 0.0958
Intolerance Scores
- LoFtool
- 0.0116
- RVIS EVS
- -2.12
- RVIS percentile EVS
- 1.52
Essentials
- Essential (CRISPR)
- N
- Essential (CRISPR2)
- N
- Essential (gene trap)
- N
- Indispensability pred.
- E
- Indispensability score
- 0.936
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |